Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

81
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
81
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

202
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
202
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

63
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
63
Imaging Studies II: Ultrasonography01:24

Imaging Studies II: Ultrasonography

78
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...
78
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

68
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
68
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

258
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

Seminars in nuclear medicine·2026
Same authorSame journal

Letter from the Editors.

Seminars in nuclear medicine·2026
Same author

Letter from the Editors.

Seminars in nuclear medicine·2026
Same author

Letter from the Editors.

Seminars in nuclear medicine·2026
Same author

Serial measurements of myocardial efficiency in patients with aortic valve stenosis: pathophysiological mechanisms and prognostic implications.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Impact of myocardial perfusion abnormalities on clinical outcomes in patients treated with percutaneous coronary intervention for chronic total occlusions.

European heart journal. Imaging methods and practice·2026

Related Experiment Video

Updated: Oct 7, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.5K

PET/CT in Bladder Cancer: An Update.

Kirsten Bouchelouche1

  • 1Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus, Denmark.

Seminars in Nuclear Medicine
|January 8, 2022
PubMed
Summary

Positron emission tomography/computed tomography (PET/CT) using FDG is valuable for staging muscle invasive bladder cancer and detecting recurrence. Emerging non-FDG PET agents show promise for improved bladder cancer imaging.

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Bladder cancer is a common urinary tract malignancy, with muscle-invasive types posing a high risk of metastasis and mortality.
  • Accurate staging is crucial for treatment selection, especially for detecting metastatic spread.

Purpose of the Study:

  • To provide an updated review on the role of Positron Emission Tomography/Computed Tomography (PET/CT) in the management of bladder cancer.
  • To discuss the current applications and future potential of PET/CT in bladder cancer diagnosis, staging, and response evaluation.

Main Methods:

  • Review of existing literature on FDG PET/CT and other PET tracers in bladder cancer.
  • Analysis of PET/CT's utility in primary staging, recurrence detection, and treatment response assessment.

More Related Videos

Photoacoustic Cystography
09:49

Photoacoustic Cystography

Published on: June 11, 2013

13.4K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.9K

Related Experiment Videos

Last Updated: Oct 7, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.5K
Photoacoustic Cystography
09:49

Photoacoustic Cystography

Published on: June 11, 2013

13.4K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.9K

Main Results:

  • FDG PET/CT is increasingly utilized for staging muscle-invasive bladder cancer and detecting post-treatment recurrence.
  • Limited studies have explored FDG PET/CT for evaluating treatment response to neoadjuvant therapies.
  • Research is emerging on non-FDG PET agents with reduced urinary excretion for potentially enhanced bladder imaging.

Conclusions:

  • PET/CT, particularly FDG PET/CT, plays a significant role in the clinical management of bladder cancer.
  • Further research into novel PET tracers is warranted to improve diagnostic accuracy and treatment monitoring in bladder cancer.